Business Wire

LEO Pharma Expands Partnering Presence with LEO Science & Tech Hub in Boston

Del

LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin, today announced the official inauguration of the LEO Science & Tech Hub in Boston by Her Royal Highness, Crown Princess Mary of Denmark. The event, which also includes participation from the Danish Minister for Business and Growth Troels Lund Poulsen, brings together members of the Boston life science community to explore opportunities for partnership and innovation.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160930005376/en/

(Graphic: LEO Science & Tech Hub)

(Graphic: LEO Science & Tech Hub)

The Hub aims to catalyze early-stage collaborations in science and technology in order to advance the treatment of skin diseases and is the first of its kind to focus on dermatology in the Greater Boston area, the world’s leading life science cluster.

“With the establishment of the LEO Science & Tech Hub at the epicenter of this world-leading biotech supercluster, LEO Pharma is poised to foster novel collaborations that can lead to significant advances in science,” says Kim Kjoeller, Executive Vice President, Global Research & Development, LEO Pharma. “By creating alliances with industry and academia here in the region, we hope to change the treatment paradigm in dermatology and improve the quality of life of people with skin diseases.”

The LEO Science & Tech Hub will build early-stage collaborations with academic centers, entrepreneurs and companies in the United States – and support collaborators in validating novel targets in skin diseases and advancing technology towards commercialization. The Hub team has access to full deal-making capabilities and can provide support in terms of seed investments and co-development, including access to LEO Pharma’s global network of dermatology expertise. Collaborators can access LEO Pharma’s preclinical and clinical expertise as well as the digital healthcare expertise of LEO Innovation Lab.

“The LEO Science & Tech Hub wants to join forces with life science innovators in the US to change the treatment paradigm for people with skin diseases and take the first steps towards precision medicine in dermatology,” says Michael Sierra, Vice President, LEO Science & Tech Hub. “By offering our collaborators access to funding and a unique global network of dermatology expertise, we want to act as catalysts for innovation and help bring new science and technology to the next stage.”

The Hub’s team of science experts will engage with partners in three areas: cognitive computer learning, imaging, and biomarkers. For example, the Hub will explore the use of smart phones to help patients monitor their disease and track treatment progress. The Hub will also explore advanced imaging technologies as a valid and reliable alternative to skin biopsies. The overall aim is to enable patients and doctors to monitor, diagnose, and treat skin diseases in a more effective and less invasive way.

The LEO Science & Tech Hub is located in the heart of the Kendall Square innovation district at the CIC in Cambridge, Massachusetts.

“We congratulate LEO Pharma on the opening of the new LEO Science & Tech Hub in Kendall Square,” said Robert K. Coughlin, President & CEO of MassBio. “We know that LEO Pharma’s collaborative spirit will cultivate new partnerships in the Hub that will advance precision medicine in dermatology and ultimately speed the development of innovative treatments for patients around the world.”

“LEO Pharma’s new dermatology-focused LEO Science & Tech Hub is a welcome addition to the many life sciences centers of excellence that are operating and innovating in and around Boston and Cambridge,” said Travis McCready, President & CEO of the Massachusetts Life Sciences Center. “Skin diseases are more common than one might expect - every year one in four Americans consult their primary care physician regarding a skin concern. We look forward to collaborating with LEO Pharma as they put down roots and form partnerships within the world’s leading ecosystem for life sciences innovation and growth.”

“We are excited for LEO Pharma to join Massachusetts’ thriving life sciences ecosystem, bringing the first center focused exclusively on dermatology to the Commonwealth,” said Charlie Baker, Governor of Massachusetts. “This new facility will advance research and the development of new treatments in the field of dermatology, while opening up new opportunities for collaboration between the life sciences communities in Massachusetts and Denmark.”

About LEO Pharma

LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 5,000 people worldwide.

For more information, visit www.leo-pharma.com
Subscribe to our YouTube channel: www.youtube.com/leopharmaglobal
Follow us on Twitter: www.twitter.com/leohealthyskin
Visit us at LinkedIn: www.linkedin.com/company/leo-pharma

About LEO Science & Tech Hub

LEO Science & Tech Hub explores cutting-edge science and technology opportunities with relevance to dermatology. By partnering with public and private institutions, the LEO Science & Tech Hub acts as a catalyst that transforms early-stage innovations and technologies into solutions that will improve the quality of life for people with skin diseases. LEO Science & Tech Hub is part of LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin.
www.leo-scitech.com

Contact information

LEO Pharma
Eva Juul Langlands, +45 4188 3094
Media Relations Manager
Global Communications
eva.langlands@leo-pharma.com
or
LaVoieHealthScience
Vivian Ni, +1 617-374-8800 ext. 109
Assistant Account Executive
vni@lavoiehealthscience.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Loxam Announces a Conditional Agreement to Acquire UK Platforms20.7.2018 14:51Pressemelding

Loxam Group (“Loxam”) announces that its wholly-owned subsidiary Nationwide Platforms Limited (“Nationwide”) has entered into a conditional agreement with HSS Hire Group plc (“HSS”) with respect to the acquisition of UK Platforms Limited (“UKP”). UKP specializes in renting powered access equipment from its 12 branches located throughout the United Kingdom. The company has approximately 130 employees and operates a fleet of 3,000 units. UKP is controlled by HSS since 2013. As part of this transaction, Nationwide has entered into a commercial agreement with HSS to provide powered access equipment to complement HSS’ existing fleet. The closing of the transaction is subject to the approval by HSS’ shareholders and the confirmation that it will not be referred to the Competition and Mergers Authority. The transaction is expected to close before year end 2018. Don Kenny, CEO of Loxam’s Powered Access Division states: “I am delighted with the acquisition of UKP which will further reinforce NW

Schlumberger Announces Second-Quarter 2018 Results20.7.2018 11:00Pressemelding

Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2018 Mar. 31, 2018 Jun. 30, 2017 Sequential Year-on-year Revenue $8,303 $7,829 $7,462 6% 11% Pretax operating income $1,094 $974 $950 12% 15% Pretax operating margin 13.2% 12.4% 12.7% 75 bps 45 bps Net income - GAAP basis $430 $525 $(74) -18% n/m Net income, excluding charges & credits* $594 $525 $488 13% 22% Diluted EPS - GAAP basis $0.31 $0.38 $(0.05) -18% n/m Diluted EPS, excluding charges & credits* $0.43 $0.38 $0.35 13% 23% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. n/m = not meaningful Schlumberger Chairman and CEO Paal Kibsgaard commented, “The second quarter was both busy and exciting for Schlumberger as we completed a number of major milestones in preparation for the broad-based global activity upturn that is now emerging. We delivered solid top-line gro

H.I.G. Capital Announces the Sale of KidsFoundation19.7.2018 19:50Pressemelding

H.I.G. Capital (“H.I.G.”), a leading global private equity investment firm with more than €21 billion of equity capital under management, announced today that one of its affiliates has entered a definitive agreement to sell the KidsFoundation Group (“KidsFoundation”), the Dutch market leader in childcare services, to Onex Corporation (“Onex”)(TSX:ONEX). Terms were not disclosed. Headquartered in Almere, the Netherlands, KidsFoundation provides high-quality childcare to nearly 30,000 children between the ages of six weeks and 12 years. H.I.G. created KidsFoundation in 2014 through the acquisition of assets from the estate of Estro Group. During H.I.G.’s ownership, the company has developed strongly with significant capital invested by H.I.G. to create a high-quality childcare offering. H.I.G. worked with KidsFoundation management to optimise the footprint of the company by exiting loss-making locations, introduce new IT systems to drive operational improvement and develop an internal M&

SIG Combibloc Group Holdings S.à r.l.: 2018 Second Quarter Results19.7.2018 16:01Pressemelding

We are pleased to announce our quarterly conference call to discuss the results of SIG Combibloc Group Holdings S.à r.l. for the second quarter ended June 30, 2018. Date: Monday, July 23, 2018 Time: 15.00 CEST / 14.00 BST / 9.00 EDT The call information will be distributed on our secure site. If you would like access to our call, please contact investor.relations@sig.biz . Regards, SIG Combibloc Group Holdings S.à r.l. View source version on businesswire.com: https://www.businesswire.com/news/home/20180719005634/en/ Contact information SIG Combibloc Group Holdings S.à r.l. Jennifer Gough investor.relations@sig.biz

NEORIS Announces Creation of Innovation Labs Worldwide to Create a Smarter Future19.7.2018 15:32Pressemelding

NEORIS, a global digital consulting services company, announced today it is consolidating the most innovative solutions it has developed in different geographies and allocating unprecedented resources to deploy a network of Innovation Labs worldwide. The main objective is to lay the foundation for the continuous development of disruptive solutions for its four core industries: Manufacturing, Financial Services, Healthcare and Telecommunications. Due to its disruptive nature, NEORIS decided that its first Innovation Lab should be housed in the Monterrey Digital Hub, which today is the first-of-its-kind as it is a space where entrepreneurs, companies, universities and investors converge to foster an ecosystem for Digital Transformation. The lab inaugurated in Monterrey, Mexico is the first of a series of Innovation Labs that will open in the different countries that NEORIS operates, and is a space where customers can experience emerging technologies through real-life scenarios. One such

CORRECTING and REPLACING Albar Capital Deploys FlexNOW19.7.2018 15:29Pressemelding

Subhead of release should read: Out-of-the-Box Multi-Asset Execution Management System (instead of Easy-to-Install Multi-Asset Execution Management System). The corrected release reads: ALBAR CAPITAL DEPLOYS FLEXNOW Out-of-the-Box Multi-Asset Execution Management System FlexTrade (@FlexTrade) today announced that Albar Capital Ltd., a new hedge fund led by Javier Velazquez (formerly of Millennium Capital Partners LLP), is now trading equities and futures using FlexNOW, FlexTrade’s new execution management system. “The FlexNOW team was instrumental in solving several of our problems,” said Jason Ruder, Trader at Albar Capital. “Not only are they helping us with our compliance requirements, they are also responsive to requests that improve my workflow.” According to Rhyd Lewis, FlexNOW Product Manager, FlexNOW’s quick onboarding and easy installation process was critical for Albar Capital’s launch on 2 July. “We had no problem integrating FlexNOW with Albar’s portfolio and risk managemen